Why the study?
To describe the nuanced management, role of noninvasive diagnostics, and challenges in targeted management of acute fulminant myocarditis secondary to Coxsackie B virus.
This case highlights the diagnostic utility of repeat serological testing and cardiac MRI in fulminant myocarditis, and describes a management strategy utilizing mechanical support, GDMT, and immunosuppression.
Answers are grounded in this paper and cite their sources.
Case of post-viral fulminant myocarditis illustrates need for prompt cardiac evaluation in febrile patients; leaves open optimal support strategies pending prospective data.
Fulminant myocarditis is a severe form of acute myocarditis, characterized by complications such as hemodynamic compromise, often requiring advanced mechanical support. It can occur as a result of infection, toxin exposure, or autoimmune processes. This is a case of a 53-year-old male with no past medical history who presented with one week of fever, shortness of breath, and upper respiratory symptoms and subsequently developed fulminant myocarditis, characterized by severe left ventricular dysfunction and cardiogenic shock requiring both inotropic and advanced mechanical support. Initial serological diagnostics were negative for a viral etiology; however, repeat testing, prompted by continued high clinical suspicion, subsequently yielded a positive Coxsackie B viral titer. The diagnosis of myocarditis was further supported by the specific distribution of late gadolinium enhancement (LGE) on cardiac MRI. We describe the nuanced management approach, including heart failure guideline-directed medical therapy (GDMT), high-dose steroids, and intravenous immunoglobulins. Additionally, we highlight the role of noninvasive diagnostics and the challenges in targeted management of fulminant myocarditis.
No takes yet. Share an insight, caveat, or question.
Seshadri et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: